Eminence Group

takes care of your health.

Product

Incidence

Source

Year

Website

EB301AP

Muscle pain

Neck 18.7% + Lower back 9.6%

28.3%

USA/CDC

2010

A

Gout

2.54%

USA/CDC

2010

A

Menstruation pain

(79.67% of female with unpleasant feeling during menstruation, 37.96% need medical care among those)

0.5 x 0.5 x 79.67% x 37.96% = 7.56%

7.56%

USA/

NLM & NIH

2010

B

EB302

Arthritis

22%

USA/CDC

2010

A

EB306

Allergic rhinitis

7.3%

USA/AHRQ

2005

C

EB301CT

No suitable authoritative incidence report (potential gross profit not yet included in the calculation)

Note:

1.) Authoritative departments:
USA
CDC: Centers for Disease Control and Prevention
NLM: National Library of Medicine
NIH: National Institutes of Health
AHRQ: Agency for Healthcare Research & Quality

 

2.) Website:

A:
http://www.cdc.gov/mmwr/PDF/wk/mm5939.pdf
http://www.rheumatology.org/Research/Prevalence_Statistics/
Or,
http://www.rheumatology.org/
then click “Research”
then click ”Prevalence Statistics”

 

In an October 2010 issue of Morbidity and Mortality Weekly Report, the Centers for Disease Control and Prevention announced the following data in estimation

1.) Muscle pains of Low back pain– 59 million and Neck pain – 30.1 million - equating to about 28.4 %. (Other kinds of muscle pain are not yet included).
2.) Nearly eight million people in the U.S. suffered from gout pain- equating to about 2.54 %.
3.) Nearly 50 million U.S. adults suffer from arthritis - equating to about 22 %.

 

B:

http://www.ncbi.nlm.nih.gov/pmc/articles/PM2888348/
Incidence of menstrual pain
PMC (supported by US National Library of Medicine and National Institutes of Health) announced that the prevalence of dysmenorrhea (menstrual pain) in adolescent girls was found to be 79.67%. Most of them, 37.96%, suffered regularly from dysmenorrhea (menstrual pain) severity.

 

C:

http://www.ahrq.gov
In 2005, approximately 22 million persons or 7.3 percent of the U.S. population reported experiencing related symptoms.
Medical spending to treat allergic rhinitis up to $11.2 billion in 2005
Percentage: 7.3 %

 

Eminence Biotech Co., Ltd.

Copyright © All Rights Reserved.